Technology that Supports the Patient Journey and Product Lifecycle
The ‘Entourage Effect’: How THC can team up with PEA to treat symptoms of Tourette syndrome
Delving into RXi’s RNAi Delivery Platform
Parasite Treatment Fights Prostate Cancer
The Convergence of Clinical Research and Clinical Practice
FDA Approves Roche Drug for Rare Blood Cancer
Expanding Breast Cancer Treatment Options: A Q&A with BriaCell on their Cancer Vaccine and their Pipeline
DDD: What clinical data do you have? WW: In a clinical study, we treated four evaluable patients with advanced cancer. One of them had a remarkable response, with metastatic breast cancer shrinking markedly in several locations. The protocol at that time only permitted five months of treatment, and when the treatment was stopped the breast…
FDA Approves Soliris for Generalized Myasthenia Gravis
FDA Approves First Gene Therapy for non-Hodgkin Lymphoma
Gene Therapy for Blindness is One Step Closer to Approval
The U.S. Food and Drug Administration’s Cellular, Tissue and Gene Therapies Advisory Committee yesterday endorsed the first gene therapy for patients with Leber congenital amaurosis, also called Biallelic RPE65-mediated inherited retinal disease. The vote was 16 to 0 in favor of the treatment, voretigene neparvovec from Spark Therapeutics. “This Advisory Committee decision is a…
Empowering Brain Tumor Patients with Information on Clinical Trials
New Device Approved for Central Sleep Apnea
Securing the Supply Chain with Molecular Tagging
10 Cancer Drugs that Made Headlines This Year
The U.S. saw a reduction in cancer deaths from 1991 to 2014. According to the latest data from the 2017 Cancer Progress Report, just released by the American Association of Cancer Research (AACR), over 2.1 million lives have been saved. The AACR cites immunotherapy and precision medicine are at the forefront of this progress. Its…
